Trademarkia Logo

Canada

C$
Trademark Search in Canada
Trumdacin

View On IC.GC.CA

Trumdacin
REGISTERED

on 3 Jan 2025

Last Applicant/ Owned by

Hangzhou DAC Biotech Co., Ltd.

Building 12, No. 260 Sixth Street, Hangzhou Economic & Technological Development Area, HangzhouZhejiang

CN

Serial Number

2069748 filed on 22nd Sept 2020

Registration Number

TMA1280267 registered on 3rd Jan 2025

Registration expiry Date

22nd Sept 2030

Correspondent Address

ROBIC AGENCE PI S.E.C./ ROBIC IP AGENCY LP

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

Trumdacin

Trademark usage description

pharmaceutical preparations, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency synd Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes; chemico-pharmaceutical preparations, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes; drugs for medical purposes, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes; medicines for human use, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes; chemical preparations for medical purposes, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes; anticancer agent; diagnostic preparations for medical or veterinary use, namely, for the treatment of cancers and immunological disorders, namely autoimmune diseases, immunologic deficiency syndromes; reagents for use in diagnostic tests for medical purposes; drugs for cancer.

Classification kind code

11

Mark Details

Serial Number

2069748

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 6th Jul 2023		Agent Changed
Submitted for opposition 22
on 1st Apr 2022		Search Recorded
Submitted for opposition 20
on 1st Apr 2022		Examiner's First Report
Submitted for opposition 223
on 1st Apr 2022		Total Provisional Refusal
Submitted for opposition 256
on 11th Oct 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 10th Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 9th Dec 2020		Created
Submitted for opposition 31
on 9th Dec 2020		Formalized
Submitted for opposition 30
on 22nd Sept 2020		Filed
Submitted for opposition 228
on 22nd Sept 2020		International Registration